Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stratametrics is a spatial biology company dedicated to advancing precision medicine through high-plex spatial multi-omics. The company was founded by a team of experts from Stanford University, including Dr. Garry Nolan, who are recognized for their pioneering work in spatial proteomics and the development of technologies like CODEX. Stratametrics is developing a next-generation imaging platform that enables the simultaneous detection of numerous proteins and transcripts within intact tissue samples at subcellular resolution. By providing a comprehensive view of the tissue microenvironment, their technology helps researchers and clinicians understand complex disease mechanisms and identify novel biomarkers. The company's mission is to make high-dimensional spatial analysis more accessible and scalable for drug development and diagnostic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stratametrics.